Clinical trialNCT07687485Not, yet, recruitingInterventional

Tricuspid Regurgitation Treatment With LAPLACE Transcatheter Tricuspid Valve Replacement System

SponsorLaplace Interventional, IncEnrollment700Cardiovascular Diseases (CVD)Heart Valve DiseasesSevere Heart Valve DiseaseSevere Tricuspid Valve RegurgitationSymptomatic Tricuspid RegurgitationTricuspid Valve Disease+2 more conditions

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The objective of this clinical study is to assess the safety and efficacy of the Laplace Transcatheter Tricuspid Valve Replacement (TTVR) System for the treatment of symptomatic subjects with at least severe tricuspid regurgitation (TR).

clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Brandon Jones, MD
Providence St. Vincent Medical Center
Principal Investigator
clinicaltrials.gov ↗
Charanjit Rihal, MD
Mayo Clinic
Principal Investigator
clinicaltrials.gov ↗
Kashish Goel, MD
Vanderbilt University Medical Center
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

No facility list is in our current data snapshot for this study. The registry record on ClinicalTrials.gov ↗ carries any published locations. Why? →

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 30 Sept 2026
Primary completion: 30 Sept 2029
Completion: 30 Sept 2038
Last update posted: 22 Jul 2026
Registered enrollment: 700
Registry id: NCT07687485

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.